These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21852619)

  • 1. Blood pressure management in acute stroke: does the Scandinavian Candesartan Acute Stroke Trial (SCAST) resolve all of the unanswered questions?
    Fischer U; Rothwell PM
    Stroke; 2011 Oct; 42(10):2995-8. PubMed ID: 21852619
    [No Abstract]   [Full Text] [Related]  

  • 2. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.
    Sandset EC; Bath PM; Boysen G; Jatuzis D; Kõrv J; Lüders S; Murray GD; Richter PS; Roine RO; Terént A; Thijs V; Berge E;
    Lancet; 2011 Feb; 377(9767):741-50. PubMed ID: 21316752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lowering blood pressure in acute stroke: the SCAST trial.
    Hankey GJ
    Lancet; 2011 Feb; 377(9767):696-8. PubMed ID: 21316753
    [No Abstract]   [Full Text] [Related]  

  • 4. Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome.
    Sandset EC; Murray GD; Bath PM; Kjeldsen SE; Berge E;
    Stroke; 2012 Aug; 43(8):2108-14. PubMed ID: 22627991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
    Nakamura T; Tsutsumi Y; Shimizu Y; Uchiyama S
    J Stroke Cerebrovasc Dis; 2010; 19(6):435-40. PubMed ID: 20702114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncholestatic acute hepatocellular injury following candesartan administration.
    Lammel-Lindemann JA; Flores-Villalba E; Martagón AJ; DeObeso-Gonzalez E; Puente-Gallegos F
    Br J Clin Pharmacol; 2018 Jan; 84(1):204-207. PubMed ID: 28841231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of candesartan in acute stroke on cognitive function and quality of life: results from the Scandinavian Candesartan Acute Stroke Trial.
    Hornslien AG; Sandset EC; Bath PM; Wyller TB; Berge E;
    Stroke; 2013 Jul; 44(7):2022-4. PubMed ID: 23660849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.
    Lee JH; Yang DH; Hwang JY; Hur SH; Cha TJ; Kim KS; Kim MH; Chun KJ; Cha GS; Hong GR; Lee SG; Kim DS; Kim DI; Chae SC
    Clin Ther; 2016 Jun; 38(6):1485-1497. PubMed ID: 27161546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage.
    Jusufovic M; Berge TE; Guo R; You S; Delcourt C; Anderson C; Bath PM; Karlson BW; Berge E; Sandset EC;
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2262-2267. PubMed ID: 31178359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased renal echogenicity in a preterm neonate. Kidneys with tubular dysplasia due to exposure to candesartan during pregnancy.
    Bald M; Holder M; Zieger M; Vochem M; Leichter HE
    Pediatr Nephrol; 2005 Nov; 20(11):1664-5, 1666-8. PubMed ID: 16082550
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST).
    Hornslien AG; Sandset EC; Igland J; Terént A; Boysen G; Bath PM; Murray GD; Berge E
    Int J Stroke; 2015 Aug; 10(6):830-5. PubMed ID: 25808741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin receptor blockers and myocardial infarction.
    Verma S; Strauss M
    BMJ; 2004 Nov; 329(7477):1248-9. PubMed ID: 15564232
    [No Abstract]   [Full Text] [Related]  

  • 13. Rash and acute nephritic syndrome due to candesartan.
    Morton A; Muir J; Lim D
    BMJ; 2004 Jan; 328(7430):25. PubMed ID: 14703542
    [No Abstract]   [Full Text] [Related]  

  • 14. Stroke: blood pressure lowering in acute stroke--scant joy from SCAST.
    Arima H; Chalmers J
    Nat Rev Cardiol; 2011 Apr; 8(7):366-8. PubMed ID: 21587216
    [No Abstract]   [Full Text] [Related]  

  • 15. Concomitant administration of candesartan cilexetil in patients on paclitaxel and carboplatin combination therapy increases risk of severe neutropenia
.
    Katsube Y; Hira D; Tsujimoto M; Koide H; Minegaki T; Ikeda Y; Morita SY; Nishiguchi K; Terada T
    Int J Clin Pharmacol Ther; 2018 Jul; 56(7):328-336. PubMed ID: 29792394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex).
    Ogihara T; Ueshima K; Nakao K; Fukiyama K; Oba K; Yasuno S; Fujimoto A; Sato T; Matsuoka H; Saruta T;
    Hypertens Res; 2011 Dec; 34(12):1295-301. PubMed ID: 21833000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
    Serebruany VL; Atar D; Hanley DF
    Cerebrovasc Dis; 2008; 26(5):563-4. PubMed ID: 18936537
    [No Abstract]   [Full Text] [Related]  

  • 18. Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T).
    Bönner G; Landers B; Bramlage P
    Vasc Health Risk Manag; 2011; 7():85-95. PubMed ID: 21415922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of olmesartan in a patient with telmisartan-induced myotoxicity: a case report.
    Barvaliya MJ; Naik VN; Shah AC; Tripathi CR
    Br J Clin Pharmacol; 2015 Jun; 79(6):1034-6. PubMed ID: 25495498
    [No Abstract]   [Full Text] [Related]  

  • 20. The X-cellent Study.
    Safar ME
    Am J Hypertens; 2006 Jan; 19(1):8-9. PubMed ID: 16461182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.